李星 博士

个人简介：

       长期致力于肝癌预后及免疫机理研究。以（共同）第一作者/通讯作者发表SCI论文18篇，总IF 194.3。因有关肿瘤的多项研究成果在2011、2014、2015、2016年美国肿瘤学年会（ASCO）及分会上被General Poster Section选中进行展示。近年主要研究髓系抑制性细胞（MDSC），主要研究成果发表于Kidney International、Nature Medicine、Immunology。

第一作者论文

1. Yu-Mei He#, Xing Li#, Michela Perego#, Yulia Nefedova, Andrew V. Kossenkov, Erik A. Jensen, Valerian Kagan, Yu-Feng Liu, Shu-Yu Fu, Qing-Jian Ye, Yan-Hong Zhou, Lai Wei, Dmitry I. Gabrilovich*, Jie Zhou*. Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation. Nat Med. 2018 Jan 15. doi: 10.1038/nm.4467. [Epub ahead of print] (IF: 29.886)
2. He CH#, Li X#, Lin JH, Xiao Q, Yu JL, Liu YF, Jiang WH, Chen C, Deng L*, Zhou J. A 2-year step-down withdrawal from inhaled corticosteroids in asthmatic children receiving immunotherapy.World J Pediatr. 2017 Dec;13(6):560-565. (IF: 1.164)
3. Dong M#, Chen ZH#, Li X #, Li XY, Wen JY, Lin Q, Ma XK, Wei L, Chen J, Ruan DY,  Lin ZX, Wang TT, Wu DH, Wu XY*. Serum Golgi protein 73 is a prognostic rather than diagnostic marker in hepatocellular carcinoma. Oncol Lett. 2017 Nov;14(5):6277-6284. (IF: 1.390)
4. Pei-Qiong Wu#, Xing Li#, Wen-Hui Jiang, Gen-Quan Yin, Ai-Hua Lei,  Qiang Xiao, Jian-Jun Huang, Zhi-Wei Xie, Li Deng*. Hypoxemia is an independent predictor of bronchiolitis obliterans following respiratory adenoviral infection in children. Springerplus. 2016 Sep 20;5(1):1622 (IF: 1.130)

1. Xing Li #, Yun Deng, Jie Chen, Dan-Yun Ruan, Zhan-Hong Chen, Yan-Fang Xing, Xiang-Yuan Wu*, Min Dong. Deceptive information and the financial burden for Chinese cancer patients. (correspondence) Lancet Oncol. 2014,15(8):e299. (IF: 33.9)
2. Xu Liu#, Xing Li #, Ning Jiang#, Ying Lei, Ling-Long Tang, Lei Chen, Guan-Qun Zhou, Ying Sun, Dan Yue, Rui Guo, Yan-Ping Mao, Wen-Fei Li, Li-Zhi Liu, Li Tian, Ai-Hua Lin, Jun Ma*. Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in China. Cancer. 2014,120(1):68-76. (IF: 5.997)
3. Xing Li #, Yan-Fang Xing, Zhan-Hong Chen, Min Dong, Xiang-Yuan Wu*. Palliative care in urban areas of China. (correspondence)Lancet Oncol. 2013,14(9):e339. (IF: 33.9)
4. Xing Li #, Min Dong#, Qu Lin, Zhan-Hong Chen, Xiao-Kun Ma, Yan-Fang Xing, Xiang-Bo Wan, Jing-Yun Wen, Li Wei, Jie Chen, Xiang-Yuan Wu*. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials. Asia Pac J Clin Oncol. 2013,9(1):86-92. (IF: 1.959)
5. Xing Li#, Yan-Fang Xing, Qu Lin, Min Dong, Xiang-Bo Wan, Xiang-Yuan Wu*. The treatment of severe hepatitis B virus reactivation after chemotherapy. (correspondence) Nat Rev Clin Oncol. 2012,9(6):350. (IF: 20.693)
6. Xing Li #, Qu Lin#, Min Dong#, Jing-Yun Wen, Li Wei, Xiao-Kun Ma, Zhan-Hong Chen, Xiang-Yuan Wu*. Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma. Leuk Lymphoma. 2010,51(9):1678-85. (IF: 2.755）

2.2通讯作者论文

1. Nan Jiang #, Xing Yan-Fang #, Hu Bo #, Tang Jian-Xin, Dong Hui-Min, He Yu-Mei, Ruan Dan-Yun, Ye Qing-Jian, Cai Jia-Rong, Ma Xiao-Kun, Chen Jie, Cai Xiu-Rong, Lin Ze-Xiao, Wu Xiang-Yuan* and Li Xing* Endoplasmic reticulum stress induced Lox-1+CD15+ polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma. Immunology. 2017 Dec 6. doi: 10.1111/imm.12876. [Epub ahead of print]. (IF: 3.701)
2. Jiang WH#, Deng L, Ye QJ, Cai JR, Cai XR, Li X*. Timing of regular egg intake for prevention of egg allergy. (correspondence)J Allergy Clin Immunol. 2017 Nov 14. pii: S0091-6749(17) 31580-4. (IF: 13.081)
3. Lin JH#, Deng L, Li X*. Recurrent tracheoesophageal fistula in an adolescent without persistent symptoms: A case report. Medicine (Baltimore). 2017 Nov;96(46):e8668. (IF: 1.804)
4. Lin JX#, Chen XW#, Chen ZH#, Huang XY, Yang JJ, Xing YF, Yin LH, Li X *, Wu XY. A multidisciplinary team approach for nutritional interventions conducted by specialist nurses in patients with advanced colorectal cancer undergoing chemotherapy: A clinical trial. Medicine (Baltimore). 2017 Jun;96(26):e7373. (IF: 1.804)
5. Yan-Fang Xing#, Rui-Ming Cai#, Qu Lin#, Qing-Jian Ye, Jian-Hua Ren, Liang-Hong Yin, Xing Li*. Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications. Kidney Int. 2017 May;91(5):1236-1242. (IF: 8.395)
6. Yan-Fang Xing#, Yu-Qi Zhou, Guo-Wei Ma, Ding-Yun Feng, Xiu-Rong Cai, Xing Li*. Issues with anti-Gr1 antibody-mediated myeloid-derived suppressor cell depletion. (correspondence) Ann Rheum Dis. 2016 Aug;75(8):e49(IF: 12.811)
7. Xiang-Yong Li#, Min-Jun Bai#, Lin-Jun Chen#, Jian-Liang Xu, Zhi-Huan Lin#， Xing Li *, Yan-Fang Xing*. Issue in statistical strategy in case-control study. (correspondence) Hepatology. 2015 Jul;62(1):320.(IF:13.246)
8. Yan-Fang Xing#,*, Xing Li#,* Normality test is needed in data description: a neglectful but vital problem. (correspondence) Kidney Int. 2013,83(5):970-1. (IF: 8.395)